Saxenda

DRUG6 trials

Sponsors

University of Leicester, NYU Langone Health, Mayo Clinic, University Hospitals Coventry and Warwickshire NHS Trust, Sciwind Biosciences APAC CO Pty. Ltd.

Conditions

CraniopharyngiomaDiabetes MellitusHypothalamic ObesityInfertility, FemaleObesityOverweightPanhypopituitarismWeight Loss

Early Phase 1

The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

RecruitingNCT06217848

Seoul National University HospitalCraniopharyngioma, Hypothalamic Obesity, Panhypopituitarism

Start: 2022-11-28End: 2024-03-08Target: 50Updated: 2024-01-23

Phase 2

Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

CompletedNCT05111912

Sciwind Biosciences APAC CO Pty. Ltd.Obesity

Start: 2021-11-30End: 2022-12-20Updated: 2023-08-21

Phase 3

Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy

CompletedNCT03115424

Mayo ClinicObesity

Start: 2017-06-22End: 2024-05-30Updated: 2024-09-27

Phase 4

Saxenda in Obesity Services (STRIVE Study)

CompletedNCT03036800

University of LeicesterDiabetes Mellitus, Obesity, Weight Loss

Start: 2017-11-28End: 2022-02-25Updated: 2024-08-13

Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery

CompletedNCT03048578

NYU Langone HealthObesity

Start: 2017-05-22End: 2021-03-02Updated: 2022-12-09

Unknown Phase

3mg Liraglutide for Overweight or Obesity

CompletedNCT03885297

University Hospitals Coventry and Warwickshire NHS TrustInfertility, Female, Obesity, Overweight

Start: 2019-01-18End: 2020-12-18Updated: 2024-06-18

Related Papers

Effectiveness of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in weight management services (STRIVE study): a multicentre, open-label, parallel-group, randomized controlled trial.

2024-02-097 citations

Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial

BMJ Open2020-02-0112 citations